{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T19:47:03Z","timestamp":1769629623868,"version":"3.49.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T00:00:00Z","timestamp":1544400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["1R01AI127024"],"award-info":[{"award-number":["1R01AI127024"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s10461-018-2358-0","type":"journal-article","created":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T07:25:20Z","timestamp":1544426720000},"page":"2146-2154","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["How Biomedical HIV Prevention Trials Incorporate Behavioral and Social Sciences Research: A Typology of Approaches"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4629-4329","authenticated-orcid":false,"given":"Amy","family":"Corneli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen","family":"Meagher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gail","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holly","family":"Peay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart","family":"Rennie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,12,10]]},"reference":[{"key":"2358_CR1","doi-asserted-by":"publisher","first-page":"b3496","DOI":"10.1136\/bmj.b3496","volume":"339","author":"S Lewin","year":"2009","unstructured":"Lewin S, Glenton C, Oxman AD. Use of qualitative methods alongside randomised controlled trials of complex healthcare interventions: methodological study. BMJ. 2009;339:b3496.","journal-title":"BMJ"},{"issue":"6","key":"2358_CR2","doi-asserted-by":"publisher","first-page":"e002889","DOI":"10.1136\/bmjopen-2013-002889","volume":"3","author":"A O\u2019Cathain","year":"2013","unstructured":"O\u2019Cathain A, Thomas KJ, Drabble SJ, Rudolph A, Hewison J. What can qualitative research do for randomised controlled trials? A systematic mapping review. BMJ Open. 2013;3(6):e002889.","journal-title":"BMJ Open"},{"issue":"2","key":"2358_CR3","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.cct.2014.06.002","volume":"38","author":"C Cooper","year":"2014","unstructured":"Cooper C, O\u2019Cathain A, Hind D, Adamson J, Lawton J, Baird W. Conducting qualitative research within Clinical Trials Units: avoiding potential pitfalls. Contemp Clin Trials. 2014;38(2):338\u201343.","journal-title":"Contemp Clin Trials"},{"issue":"4","key":"2358_CR4","first-page":"371","volume":"75","author":"P Gaist","year":"2017","unstructured":"Gaist P, Stirratt MJ. The roles of behavioral and social science research in the fight against HIV\/AIDS: a functional framework. JAIDS. 2017;75(4):371\u201381.","journal-title":"JAIDS"},{"issue":"Suppl 2","key":"2358_CR5","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1186\/1758-2652-14-S2-S3","volume":"14","author":"KM MacQueen","year":"2011","unstructured":"MacQueen KM. Framing the social in biomedical HIV prevention trials: a 20-year retrospective. J Int AIDS Soc. 2011;14(Suppl 2):S3.","journal-title":"J Int AIDS Soc"},{"key":"2358_CR6","unstructured":"UNAIDS. Ethical considerations in biomedical HIV prevention trials. Joint United Nations Programme on HIV\/AIDS; 2012."},{"key":"2358_CR7","unstructured":"UNAIDS. Good participatory practice: Guidelines for biomedical HIV prevention trials. Joint United Nations Programme on HIV\/AIDS; 2011."},{"key":"2358_CR8","unstructured":"OAR. OAR History: NIH Office of AIDS Research. \n                    https:\/\/www.oar.nih.gov\/about_oar\/history.asp\n                    \n                  . Accessed 1 Oct 2018."},{"key":"2358_CR9","unstructured":"NIAID. Centers for AIDS Research Mission: NIH National Institute of Allergy and Infectious Diseases; updated March 2017. \n                    https:\/\/www.niaid.nih.gov\/research\/centers-aids-research-mission\n                    \n                  . Accessed 1 Oct 2018."},{"key":"2358_CR10","unstructured":"CFAR. Social and Behavioral Science Core: About: University of North Carolina Center for AIDS Research; updated 2017. \n                    http:\/\/unccfar.org\/portfolio\/social-behavioral-science\/\n                    \n                  . Accessed 1 Oct 2018."},{"issue":"5","key":"2358_CR11","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1097\/QAD.0b013e328337798a","volume":"24","author":"NS Padian","year":"2010","unstructured":"Padian NS, McCoy SI, Balkus JE, Wasserheit JN. Weighing the gold in the gold standard: challenges in HIV prevention research. AIDS. 2010;24(5):621\u201335.","journal-title":"AIDS"},{"issue":"24","key":"2358_CR12","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1056\/NEJMoa0911486","volume":"362","author":"CS Chasela","year":"2010","unstructured":"Chasela CS, Hudgens MG, Jamieson DJ, Kayira D, Hosseinipour MC, Kourtis AP, et al. Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. N Engl J Med. 2010;362(24):2271\u201381.","journal-title":"N Engl J Med"},{"issue":"1","key":"2358_CR13","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.cct.2006.08.003","volume":"28","author":"AL Corneli","year":"2007","unstructured":"Corneli AL, Piwoz EG, Bentley ME, Moses A, Nkhoma JR, Tohill BC, et al. Involving communities in the design of clinical trial protocols: the BAN Study in Lilongwe, Malawi. Contemp Clin Trials. 2007;28(1):59\u201367.","journal-title":"Contemp Clin Trials."},{"issue":"4","key":"2358_CR14","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1525\/jer.2006.1.4.45","volume":"1","author":"AL Corneli","year":"2006","unstructured":"Corneli AL, Bentley ME, Sorenson JR, Henderson GE, van der Horst C, Moses A, et al. Using formative research to develop a context-specific approach to informed consent for clinical trials. J Empir Res Hum Res Ethics. 2006;1(4):45\u201360.","journal-title":"J Empir Res Hum Res Ethics."},{"issue":"2","key":"2358_CR15","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/s10461-011-9977-z","volume":"16","author":"AL Corneli","year":"2012","unstructured":"Corneli AL, Sorenson JR, Bentley ME, Henderson GE, Bowling JM, Nkhoma J, et al. Improving participant understanding of informed consent in an HIV-prevention clinical trial: a comparison of methods. AIDS Behav. 2012;16(2):412\u201321.","journal-title":"AIDS Behav"},{"issue":"5","key":"2358_CR16","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1202614","volume":"367","author":"L Damme Van","year":"2012","unstructured":"Van Damme L, Corneli A, Ahmed K, Agot K, Lombaard J, Kapiga S, et al. Preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2012;367(5):411\u201322.","journal-title":"N Engl J Med"},{"issue":"5","key":"2358_CR17","first-page":"555","volume":"67","author":"A Corneli","year":"2014","unstructured":"Corneli A, Wang M, Agot K, Ahmed K, Lombaard J, Van Damme L. Perception of HIV risk and adherence to a daily, investigational pill for HIV prevention in FEM-PrEP. JAIDS. 2014;67(5):555\u201363.","journal-title":"JAIDS."},{"issue":"9749","key":"2358_CR18","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/S0140-6736(10)61086-0","volume":"376","author":"S McCormack","year":"2010","unstructured":"McCormack S, Ramjee G, Kamali A, Rees H, Crook AM, Gafos M, et al. PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial. Lancet. 2010;376(9749):1329\u201337.","journal-title":"Lancet"},{"issue":"7","key":"2358_CR19","doi-asserted-by":"publisher","first-page":"e11600","DOI":"10.1371\/journal.pone.0011600","volume":"5","author":"R Pool","year":"2010","unstructured":"Pool R, Montgomery CM, Morar NS, Mweemba O, Ssali A, Gafos M, et al. A mixed methods and triangulation model for increasing the accuracy of adherence and sexual behaviour data: the microbicides development programme. PLoS ONE. 2010;5(7):e11600.","journal-title":"PLoS ONE"},{"issue":"7","key":"2358_CR20","doi-asserted-by":"publisher","first-page":"e11632","DOI":"10.1371\/journal.pone.0011632","volume":"5","author":"R Pool","year":"2010","unstructured":"Pool R, Montgomery CM, Morar NS, Mweemba O, Ssali A, Gafos M, et al. Assessing the accuracy of adherence and sexual behaviour data in the MDP301 vaginal microbicides trial using a mixed methods and triangulation model. PLoS ONE. 2010;5(7):e11632.","journal-title":"PLoS ONE"},{"issue":"Suppl 2","key":"2358_CR21","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1186\/1758-2652-14-S2-S4","volume":"14","author":"CM Montgomery","year":"2011","unstructured":"Montgomery CM, Pool R. Critically engaging: integrating the social and the biomedical in international microbicides research. J Int AIDS Soc. 2011;14(Suppl 2):S4.","journal-title":"J Int AIDS Soc."},{"issue":"5","key":"2358_CR22","first-page":"463","volume":"59","author":"NC Ware","year":"2012","unstructured":"Ware NC, Wyatt MA, Haberer JE, Baeten JM, Kintu A, Psaros C, et al. What\u2019s love got to do with it? Explaining adherence to oral antiretroviral pre-exposure prophylaxis for HIV-serodiscordant couples. JAIDS. 2012;59(5):463\u20138.","journal-title":"JAIDS."},{"issue":"5","key":"2358_CR23","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1056\/NEJMoa1108524","volume":"367","author":"JM Baeten","year":"2012","unstructured":"Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399\u2013410.","journal-title":"N Engl J Med"},{"issue":"5","key":"2358_CR24","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1086\/428404","volume":"191","author":"NM Flynn","year":"2005","unstructured":"Flynn NM, Forthal DN, Harro DC, Judson FN, Mayer KH, Para MF, et al. Placebo-controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent\u00a0HIV-1\u00a0infection. J Infect Dis. 2005;191(5):654\u201365.","journal-title":"J Infect Dis"},{"issue":"1","key":"2358_CR25","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1080\/09540120412331305124","volume":"17","author":"G Guest","year":"2005","unstructured":"Guest G, McLellan-Lemal E, Matia DM, Pickard R, Fuchs J, McKirnan D, et al. HIV vaccine efficacy trial participation: men who have sex with men\u2019s experiences of risk reduction counselling and perceptions of risk behaviour change. AIDS Care. 2005;17(1):46\u201357.","journal-title":"AIDS Care."},{"issue":"6","key":"2358_CR26","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1056\/NEJMoa1402269","volume":"372","author":"JM Marrazzo","year":"2015","unstructured":"Marrazzo JM, Ramjee G, Richardson BA, Gomez K, Mgodi N, Nair G, et al. Tenofovir-based preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2015;372(6):509\u201318.","journal-title":"N Engl J Med"},{"key":"2358_CR27","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1472-6874-14-88","volume":"14","author":"B Magazi","year":"2014","unstructured":"Magazi B, Stadler J, Delany-Moretlwe S, Montgomery E, Mathebula F, Hartmann M, et al. Influences on visit retention in clinical trials: insights from qualitative research during the VOICE trial in Johannesburg, South Africa. BMC Womens Health. 2014;14:88.","journal-title":"BMC Womens Health."},{"key":"2358_CR28","unstructured":"Rees H, Delany-Moretiwe SA, Lombard C, Baron D, Panchia R, Myer L, et al. FACTS 001 phase III trial of pericoital tenofovir 1% gel for HIV prevention in women. Conference on Retroviruses and Opportunistic Infections (CROI); 23\u201326 February; Seattle, Washington 2015."},{"key":"2358_CR29","unstructured":"Stadler J, Delany-Moretlwe S, Baron D, Ju S, Gray G, Rees H, et al. Adherence to topical PrEP: qualitative findings from the FACTS 001 trial. 21st International AIDS Conference; 18\u201322, July, 2016; Durban, South Africa 2016."},{"issue":"4","key":"2358_CR30","doi-asserted-by":"publisher","first-page":"e0125458","DOI":"10.1371\/journal.pone.0125458","volume":"10","author":"A Corneli","year":"2015","unstructured":"Corneli A, Perry B, Agot K, Ahmed K, Malamatsho F, Van Damme L. Facilitators of adherence to the study pill in the FEM-PrEP clinical trial. PLoS ONE. 2015;10(4):e0125458.","journal-title":"PLoS ONE"},{"issue":"4","key":"2358_CR31","first-page":"452","volume":"71","author":"A Corneli","year":"2016","unstructured":"Corneli A, Perry B, McKenna K, Agot K, Ahmed K, Taylor J, et al. Participants\u2019 explanations for nonadherence in the FEM-PrEP clinical trial. JAIDS. 2016;71(4):452\u201361.","journal-title":"JAIDS."},{"issue":"5","key":"2358_CR32","first-page":"578","volume":"68","author":"AL Corneli","year":"2015","unstructured":"Corneli AL, McKenna K, Perry B, Ahmed K, Agot K, Malamatsho F, et al. The science of being a study participant: FEM-PrEP participants\u2019 explanations for overreporting adherence to the study pills and for the whereabouts of unused pills. JAIDS. 2015;68(5):578\u201384.","journal-title":"JAIDS."},{"issue":"46","key":"2358_CR33","doi-asserted-by":"publisher","first-page":"8417","DOI":"10.1016\/j.vaccine.2011.08.001","volume":"29","author":"M Bakari","year":"2011","unstructured":"Bakari M, Aboud S, Nilsson C, Francis J, Buma D, Moshiro C, et al. Broad and potent immune responses to a low dose intradermal HIV-1 DNA boosted with HIV-1 recombinant MVA among healthy adults in Tanzania. Vaccine. 2011;29(46):8417\u201328.","journal-title":"Vaccine."},{"issue":"3","key":"2358_CR34","doi-asserted-by":"publisher","first-page":"e90938","DOI":"10.1371\/journal.pone.0090938","volume":"9","author":"EA Tarimo","year":"2014","unstructured":"Tarimo EA, Munseri P, Aboud S, Bakari M, Mhalu F, Sandstrom E. Experiences of social harm and changes in sexual practices among volunteers who had completed a phase I\/II HIV vaccine trial employing HIV-1 DNA priming and HIV-1 MVA boosting in Dar es Salaam, Tanzania. PLoS ONE. 2014;9(3):e90938.","journal-title":"PLoS ONE"},{"key":"2358_CR35","unstructured":"OBSSR. The Office of Behavioral and Social Sciences Research: Strategic Plan 2017-2021. 2016."},{"issue":"Suppl 2","key":"2358_CR36","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s10461-016-1367-0","volume":"20","author":"MI Fernandez","year":"2016","unstructured":"Fernandez MI, Wheeler DP, Alfonso SV. Embedding HIV mentoring programs in HIV research networks. AIDS Behav. 2016;20(Suppl 2):281\u20137.","journal-title":"AIDS Behav"},{"issue":"2","key":"2358_CR37","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s10461-016-1487-6","volume":"20","author":"M Magnus","year":"2016","unstructured":"Magnus M, Castel A. Breaking down the siloes: developing effective multidisciplinary HIV research teams. AIDS Behav. 2016;20(2):273\u201380.","journal-title":"AIDS Behav"},{"issue":"2 Suppl","key":"2358_CR38","doi-asserted-by":"publisher","first-page":"S211","DOI":"10.1016\/j.amepre.2008.05.018","volume":"35","author":"PL Mabry","year":"2008","unstructured":"Mabry PL, Olster DH, Morgan GD, Abrams DB. Interdisciplinarity and systems science to improve population health: a view from the NIH Office of Behavioral and Social Sciences Research. Am J Prev Med. 2008;35(2 Suppl):S211\u201324.","journal-title":"Am J Prev Med"},{"issue":"1","key":"2358_CR39","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1037\/hea0000464","volume":"36","author":"WT Riley","year":"2017","unstructured":"Riley WT. Behavioral and social sciences at the National Institutes of Health: methods, measures, and data infrastructures as a scientific priority. Health Psychol. 2017;36(1):5\u20137.","journal-title":"Health Psychol"},{"issue":"4","key":"2358_CR40","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1111\/j.1748-720X.2012.00728.x","volume":"40","author":"GE Henderson","year":"2012","unstructured":"Henderson GE, Juengst ET, King NM, Kuczynski K, Michie M. What research ethics should learn from genomics and society research: lessons from the ELSI Congress of 2011. J Law Med Ethics. 2012;40(4):1008\u201324.","journal-title":"J Law Med Ethics."},{"issue":"7","key":"2358_CR41","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/gim.2016.183","volume":"19","author":"PL Sankar","year":"2017","unstructured":"Sankar PL, Parker LS. The Precision Medicine Initiative\u2019s All of Us Research Program: an agenda for research on its ethical, legal, and social issues. Genet Med. 2017;19(7):743\u201350.","journal-title":"Genet Med."}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-018-2358-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10461-018-2358-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-018-2358-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T19:08:44Z","timestamp":1575918524000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10461-018-2358-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,10]]},"references-count":41,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["2358"],"URL":"https:\/\/doi.org\/10.1007\/s10461-018-2358-0","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,10]]},"assertion":[{"value":"10 December 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants performed by any of the authors for the purpose of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}